About this trial
Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide more accurate and clinically relevant data on the outcomes of metabolic surgery (MS) in patients with severe obesity compared to traditional methods.
To achieve this objective, the investigators propose the following aims:
Aim 1: Evaluate the effectiveness of different body composition measurement tools in assessing outcomes in patients with severe obesity undergoing MS.
Aim 2: Assess the changes in body composition and muscle strength following MS.
Aim 3: Compare body compositions changes between SG and RYGB patients.
Eligibility criteria
Qualifiers
Being either male or female
Being an adult greater or equal to 18 years of age
BMI ≥40 kg/m2
Weigh less than 440 pounds
Disqualifiers
Previous bariatric surgery or other complex abdominal surgery
Poorly controlled medical or psychiatric disorders
For women in child-bearing ages, being pregnant or attempting to become pregnant or currently breastfeeding
Having metal-containing objects in their body that may cause artifact on MRI
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Pennington Biomedical Research Center
Lead sponsor
Our Lady of the Lake Hospital
Collaborator